Showing results (841-850 of 868) with videos related to

Sort By:
Pageof 87
Nature Medicine|March 30, 2026
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trialZev A Wainberg, Gulam A Manji, Nathan Bahary, et al.
Nature Communications|March 21, 2024
A structure-based designed small molecule depletes hRpn13Pru and a select group of KEN box proteinsXiuxiu Lu, Monika Chandravanshi, Venkata R Sabbasani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2013
Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testingDaniel D Buchanan, Yen Y Tan, Michael D Walsh, et al.
Molecular Psychiatry|April 30, 2014
Copy number variation in schizophrenia in SwedenJ P Szatkiewicz, C O'Dushlaine, G Chen, et al.
British Journal of Cancer|January 16, 2014
Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and ratsM J Walters, K Ebsworth, R D Berahovich, et al.
BMJ Open|February 5, 2024
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trialGavin Brittain, Jennifer Petrie, Kate E M Duffy, et al.
Journal of Medicinal Chemistry|April 29, 2026
Discovery of Casdatifan, Part I: Design and Characterization of Tetrahydroquinoline Inhibitors of Hypoxia-Inducible Factor-2αGuillaume Mata, Artur K Mailyan, Samuel L Drew, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 11, 2012
Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registryMichael D Walsh, Daniel D Buchanan, Sally-Ann Pearson, et al.
Journal of Medicinal Chemistry|July 3, 2020
Discovery of AB680: A Potent and Selective Inhibitor of CD73Kenneth V Lawson, Jaroslaw Kalisiak, Erick A Lindsey, et al.
Gut|March 12, 2014
Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relativesAung Ko Win, Daniel D Buchanan, Christophe Rosty, et al.
Pageof 87